Chicago, IL · Founded 2016 · Privately Held (backing)
Developer of biopharmaceuticals intended to offer therapeutics for food allergies. ClostraBio is based in Chicago, IL and was founded in 2016. It was valued at $16 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $14.2 million across 1 recorded round; the latest was a $9.9 million early-stage round in Sep 2022.
PMV mark · valuation
$16.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$14.2M
Last round
Early Stage VC
Sep 2022
Team — not yet on record
No current team members for ClostraBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ClostraBio with a free account
·Watch ClostraBio: the Monday email on marks, rounds and moves
